基本信息
浏览量:231
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
个人简介
She is a member of the Italian Association of Medical Oncology (AIOM), of the European Society for Medical Oncology (ESMO), of the American Society of Clinical Oncology (ASCO), of the European Association for the Study of the Liver (EASL), of the International Liver Cancer Association (ILCA).
She is a member of the AIOM Guidelines Writing Committee on Hepatocellular Carcinoma, of the Scientific Committee of the Italian Group for the Study of Digestive Tract Cancers (GISCAD) Foundation, of the Scientific Committee of the Suisse Liver Cancer Foundation, and of the ILCA Communication Committee. She is author of more than 100 articles published in peer-reviewed journals on the development of new treatments and biomarkers for gastrointestinal cancers. She is Associate Editor for Liver Cancer International, member of the Editorial Board of Journal of Hepatology and Scientific Reports. She is ad-hoc reviewer for several international scientific journals. She is speaker, chairman, discussant, member of the organizing and scientific committee at national and international congresses and conferences.
Lorenza Rimassa has a long-standing interest in the field of clinical and translational cancer research, and she has been involved in more than 100 clinical trials (phase 1-2-3). From 2005, she focused her interest on patients with gastrointestinal cancers, including hepatocellular carcinoma and biliary tract cancers, treated with new drugs in national and international clinical trials. From 2012, she is principal investigator, member of the steering committee, or of the data monitoring committee for national and international, multicenter, phase 1-2-3 clinical and translational trials of new drugs for gastrointestinal cancers, especially hepatocellular carcinoma and biliary tract cancers, including chemotherapy, small molecules, monoclonal antibodies, immuno-oncology drugs.
She is a member of the AIOM Guidelines Writing Committee on Hepatocellular Carcinoma, of the Scientific Committee of the Italian Group for the Study of Digestive Tract Cancers (GISCAD) Foundation, of the Scientific Committee of the Suisse Liver Cancer Foundation, and of the ILCA Communication Committee. She is author of more than 100 articles published in peer-reviewed journals on the development of new treatments and biomarkers for gastrointestinal cancers. She is Associate Editor for Liver Cancer International, member of the Editorial Board of Journal of Hepatology and Scientific Reports. She is ad-hoc reviewer for several international scientific journals. She is speaker, chairman, discussant, member of the organizing and scientific committee at national and international congresses and conferences.
Lorenza Rimassa has a long-standing interest in the field of clinical and translational cancer research, and she has been involved in more than 100 clinical trials (phase 1-2-3). From 2005, she focused her interest on patients with gastrointestinal cancers, including hepatocellular carcinoma and biliary tract cancers, treated with new drugs in national and international clinical trials. From 2012, she is principal investigator, member of the steering committee, or of the data monitoring committee for national and international, multicenter, phase 1-2-3 clinical and translational trials of new drugs for gastrointestinal cancers, especially hepatocellular carcinoma and biliary tract cancers, including chemotherapy, small molecules, monoclonal antibodies, immuno-oncology drugs.
研究兴趣
论文共 475 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Clinical liver diseaseno. 1 (2024)
F. Berardi,M. Soleri, A. Bertazzoni, F. Fortunato,R. Ceriani,F. Colapietro,N. Pugliese,C. Masetti,V. Pedicini,D. Poretti,L. Rimassa,T. Comito,
Digestive and Liver Disease (2024): S87-S88
European Journal of Cancer (2024): 114196
JHEP REPORTSno. 2 (2024): 100982-100982
Monica Niger, Federico Nichetti,Lorenzo Fornaro,Chiara Pircher,Federica Morano,Federica Palermo,Lorenza Rimassa,Tiziana Pressiani,Rossana Berardi, Andrea Casadei Gardini,Elisa Sperti, Lisa Salvatore,
BMC CANCERno. 1 (2024)
C. Celsa, G. Cabibbo,C.A.M. Fulgenzi,B. Scheiner,A. D'Alessio,G.F. Manfredi,B. Stefanini, T. Marron,A. Saeed,M. Pinter,Y. Huang,A. Pillai,
Digestive and Liver Disease (2024): S255-S78
Ciro Celsa,Giuseppe Cabibbo,Claudia Angela Maria Fulgenzi, Salvatore Battaglia,Marco Enea,Bernhard Scheiner, Antonio D'Alessio,Giulia F Manfredi,Bernardo Stefanini, Naoshi Nishida,Peter R Galle,Kornelius Schulze,
Hepatology (Baltimore, Md.) (2024)
G. Milardi,B. Franceschini,C. Camisaschi, G. Costa,C. Soldani,P. Uva, D. Cangelosi,R. Carriero, G. Lodetti-Zangrandi, I. Malenica,M. Erreni,T. Pressiani,
Digestive and Liver Disease (2024): S94-S95
加载更多
作者统计
#Papers: 454
#Citation: 11730
H-Index: 51
G-Index: 100
Sociability: 8
Diversity: 3
Activity: 196
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn